Selenium enhances the anti-angiogenic effects of bevacuzimab (Anti-VEGF antibody) in human acute myeloid leukemia xenograft models

被引：2
|
作者：
Doro, Nathaniel C. [1 ]
Lal, Deepika [1 ]
Rustum, Youcef [1 ]
Wang, Eunice S. [1 ,2 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4216.4216
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4216
引用
收藏
页码：121B / 122B
页数：2
相关论文
共 50 条
  • [1] An antibody directed against PDGF receptor β enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody
    Shen, Juqun
    Vil, Marie D.
    Zhang, Haifan
    Tonra, James R.
    Rong, Ling L.
    Damoci, Chris
    Prewett, Marie
    Deevi, Dhanvanthri S.
    Kearney, Jessica
    Surguladze, David
    Jimenez, Xenia
    Iacolina, Michelle
    Bassi, Rajiv
    Zhou, Kai
    Balderes, Paul
    Mangalampalli, Venkat R. M.
    Loizos, Nick
    Ludwig, Dale L.
    Zhu, Zhenping
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 357 (04) : 1142 - 1147
  • [2] Anti-angiogenic treatment concepts of acute myeloid leukemia
    Fiedler, W.
    Loges, S.
    Schuch, G.
    Bokemeyer, C.
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 : 71 - 72
  • [3] RNA aptamers with anti-VEGF, anti-angiogenic and anti-prostate tumor activity
    Zhang, S
    Cheng, L
    Xu, W
    Dominguez, J
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 188A - 188A
  • [4] RNA aptamers with anti-VEGF, anti-angiogenic and anti-prostate tumor activity
    Zhang, S
    Cheng, L
    Xu, W
    Dominguez, J
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 188A - 188A
  • [5] Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer
    Bertolini, Francesco
    Marighetti, Paola
    Martin-Padura, Ines
    Mancuso, Patrizia
    Hu-Lowe, Dana D.
    Shaked, Yuval
    D'Onofrio, Alberto
    [J]. DRUG DISCOVERY TODAY, 2011, 16 (23-24) : 1052 - 1060
  • [6] Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway
    Itatani, Yoshiro
    Kawada, Kenji
    Yamamoto, Takamasa
    Sakai, Yoshiharu
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [7] Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies
    Reichert, F
    Barak, V
    Tarshis, M
    Prindull, G
    Tarshis, E
    Ben-Ishay, Z
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (01) : 41 - 46
  • [8] ESCAPE FROM ANTI-ANGIOGENIC THERAPY? PHENOTYPIC CHANGES INDUCED BY ANTI-VEGF TREATMENT
    Grau, S. J.
    Thorsteinsdottir, J.
    Winkler, F.
    von Baumgarten, L.
    Tonn, J.
    Goldbrunner, R. H.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1142 - 1142
  • [9] PHENOTYPIC CHANGES INDUCED BY ANTI-VEGF TREATMENT-A LINK TO RESISTANCE MECHANISMS IN ANTI-ANGIOGENIC THERAPIES?
    Grau, Stefan
    Thorsteinsdottir, Jun
    Tonn, Joerg-Christian
    Goldbrunner, Roland
    Von Baumgarten, Louisa
    Winkler, Frank
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 773 - 773
  • [10] Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft
    Auyeung, Kathy Ka-Wai
    Law, Pui-Ching
    Ko, Joshua Ka-Shun
    [J]. ONCOLOGY REPORTS, 2012, 28 (06) : 2188 - 2194
12345